Mirati Therapeutics (acquired by Bristol Meyers Squibb) was searching for a major way to package and promote its Patient Support Program, Mirati & Me, ahead of the launch of breakthrough non-small cell lung cancer (NSCLC) treatment KRAZATI®.

So, we created an entirely new and interactive website highlighting Mirati & Me and its offerings for patients and HCPs.